Astec Lifesciences Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sales

458.18

628.17

676.57

554.87

522.22

Operating profit

-5.90

76.26

154.08

111.51

85.20

Interest

25.24

20.74

9.09

4.79

12.64

Gross profit

-25.56

68.56

155.46

114.39

84.50

EPS (Rs)

-23.96

13.02

45.83

33.03

24.26

Other income

5.58

13.04

10.46

7.67

11.93

Stock adjustment

0.46

-59.59

-58.00

-2.55

4.73

Raw material

318.82

460.83

444.82

344.60

333.44

Power and fuel

-

-

-

-

-

Employee expenses

61.74

52.26

50.31

38.35

29.92

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

83.06

98.40

85.36

62.97

68.93

Provisions made

-

-

-

-

-

Depreciation

36.31

33.71

34.42

25.71

23.22

Taxation

-14.89

9.33

31.22

23.98

13.80

Net profit / loss

-46.99

25.52

89.82

64.69

47.47

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

19.61

19.61

19.60

19.59

19.57

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-1.29

12.14

22.77

20.10

16.32

GPM (%)

-5.51

10.69

22.63

20.33

15.82

NPM (%)

-10.13

3.98

13.07

11.50

8.89